NCT03826875CompletedPhase 2
Poststroke Depression in Hemorrhagic Stroke
Preventative Treatment of Depression in Survivors of Aneurysmal Subarachnoid Hemorrhage
Source: ClinicalTrials.gov · Last updated 6 Aug 2025
Brief summary (registry, in English)
A double-blinded placebo-controlled randomized trial to evaluate the effect of preventative treatment of depression in survivors of aneurysmal subarachnoid hemorrhage (aSAH), a type of stroke.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- First submitted
- 28 Jan 2019
- Start date
- 1 Mar 2019
- Primary completion date
- 7 May 2025
- Lead sponsor
- University of Washington
- Diseases
- Stroke
- NCT number
- NCT03826875
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 8
- From 1 Mar 2019 to the primary completion date, 7 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients currently receiving therapy for depression or related mental health diagnoses before admission will be excluded.
- Patients with medical contraindications to fluoxetine therapy will be excluded.
Other illness
- Patients with a comorbidity or cognitive impairment (as determined by a recruiter-administered Montreal Cognitive Assessment; Patients scoring \>26 are considered of appropriate cognitive function for consent) that precludes informed consent and participation in the research interviews will be excluded.
Other
- Non-English speaking patients will be excluded.
- Pregnant patients or patients considering pregnancy during the trial period at the time of consent will be excluded.
- Patients with active psychosis will be excluded.
- Patients who are incarcerated or in police custody will be excluded.
Who the study is looking for
- Patients 18-85 years of age aged 18 years and older will be included.
- Patients admitted for subarachnoid hemorrhage from a ruptured cerebral aneurysm will be included.
- Only patients who provide informed consent will be included.
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Harborview Medical Center Coordinator of this site? Confirm its status | Seattle | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.